Insider Transactions Reported by 18 Insiders of TransMedics Group, Inc.

Symbol
TMDX on Nasdaq
Location
Andover, MA

Insiders trading volume in the past year

TransMedics Group, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Waleed H. Hassanein President & CEO, Director $72,740,697 +$2,982,471 +4.3% 17 Nov 2025
EDWIN M. KANIA JR Director $28,371,573 22 May 2025
JAMES R. TOBIN Director $16,379,057 22 May 2025
Stephen Gordon Chief Financial Officer $2,895,173 03 Jun 2024
Tamer I. Khayal Chief Commercial Officer $2,754,690 -$183,967 -6.3% 03 Mar 2025
Nicholas Corcoran SVP of Supply Chain and Operations, Exhibit List: Exhibit 24 - Power of Attorney $2,704,169 24 Feb 2025
Miriam Provost VP, Global Regulatory Affairs $2,103,421 13 Dec 2023
Gerardo Hernandez Chief Financial Officer $2,103,235 -$128,450 -5.8% 04 Dec 2025
Anil P. Ranganath Senior Vice President, General Counsel and Secretary $2,026,545 -$531,563 -21% 25 Nov 2025
David Weill Director $1,682,257 -$783,880 -32% 03 Dec 2025
John F. Sullivan VP of Quality & Engineering $1,285,855 30 Aug 2021
John F. Carey VP of Operations $1,272,071 01 Feb 2023
LAURA DAMME VP, Clinical Affairs $512,162 20 Feb 2023
Stephanie Lovell Director $375,173 22 May 2025
Thomas James Gunderson Director $375,173 22 May 2025
MERILEE RAINES Director $375,173 22 May 2025
Edward M. Basile Director $373,869 -$2,386,342 -86% 29 Oct 2025
Rakesh P. Godhani Chief Digital Officer 04 Aug 2021

Recent Insider Transactions by Companies or Individuals for TransMedics Group, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.